Literature DB >> 15383566

Melanoma differentiation-associated gene-7/IL-24 gene enhances NF-kappa B activation and suppresses apoptosis induced by TNF.

Sita Aggarwal1, Yasunari Takada, Abner M Mhashilkar, Kerry Sieger, Sunil Chada, Bharat B Aggarwal.   

Abstract

Melanoma differentiation-associated gene-7 (mda-7), also referred to as IL-24, is a novel growth regulatory cytokine that has been shown to regulate the immune system by inducing the expression of inflammatory cytokines, such as TNF, IL-1, and IL-6. Whether the induction of these cytokines by MDA-7 is mediated through activation of NF-kappaB or whether it regulates cytokine signaling is not known. In the present report we investigated the effect of MDA-7 on NF-kappaB activation and on TNF-induced NF-kappaB activation and apoptosis in human embryonic kidney 293 cells. Stable or transient transfection with mda-7 into 293 cells failed to activate NF-kappaB. However, TNF-induced NF-kappaB activation was significantly enhanced in mda-7-transfected cells, as indicated by DNA binding, p65 translocation, and NF-kappaB-dependent reporter gene expression. Mda-7 transfection also potentiated NF-kappaB reporter activation induced by TNF receptor-associated death domain and TNF receptor-associated factor-2. Cytoplasmic MDA-7 with deleted signal sequence was as effective as full-length MDA-7 in potentiating TNF-induced NF-kappaB reporter activity. Secretion of MDA-7 was not required for the potentiation of TNF-induced NF-kappaB activation. TNF-induced expression of the NF-kappaB-regulated gene products cyclin D1 and cyclooxygenase-2, were significantly up-regulated by stable expression of MDA-7. Furthermore, MDA-7 expression abolished TNF-induced apoptosis, and suppression of NF-kappaB by IkappaBalpha kinase inhibitors enhanced apoptosis. Overall, our results indicate that stable or transient MDA-7 expression alone does not substantially activate NF-kappaB, but potentiates TNF-induced NF-kappaB activation and NF-kappaB-regulated gene expression. Potentiation of NF-kappaB survival signaling by MDA-7 inhibits TNF-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383566     DOI: 10.4049/jimmunol.173.7.4368

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activity.

Authors:  Hong Zhou; Yuying Liu; Lawrence H Cheung; Sehoon Kim; Weihe Zhang; Khalid A Mohamedali; Preetha Anand; Walter N Hittelman; Bharat B Aggarwal; Michael G Rosenblum
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

2.  The role of nuclear factor-kappaB in the effect of angiotensin II in the paraventricular nucleus in protecting the gastric mucosa from ischemia-reperfusion injury in rats.

Authors:  Yong-Mei Zhang; Er-Qing Wei; Xia Hu; Wei-Li Qiao; Yue Shi; Ming Xu; Jian-Fu Zhang
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

3.  [DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo.

Authors:  S Aggarwal; M W Ndinguri; R Solipuram; N Wakamatsu; R P Hammer; D Ingram; W Hansel
Journal:  Int J Cancer       Date:  2011-07-20       Impact factor: 7.396

4.  Interleukin-24 and its receptors.

Authors:  Mai Wang; Peng Liang
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

5.  Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells.

Authors:  Sita Aggarwal; Seung-Wook Kim; Kyounga Cheon; Fazal H Tabassam; Joo-Heon Yoon; Ja Seok Koo
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

6.  Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma.

Authors:  Giang Huong Nguyen; Aaron J Schetter; David B Chou; Elise D Bowman; Ronghua Zhao; Jason E Hawkes; Ewy A Mathé; Kensuke Kumamoto; Yiqiang Zhao; Anuradha Budhu; Nobutoshi Hagiwara; Xin Wei Wang; Masao Miyashita; Alan G Casson; Curtis C Harris
Journal:  Clin Cancer Res       Date:  2010-10-14       Impact factor: 12.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.